小结
定义
病史和体格检查
其他诊断因素
- paresthesias/cold sensation/cyanosis in limb or finger
- ulceration/gangrene
- claudication
- rest pain
- superficial thrombophlebitis
- cold limb or finger
- pale limb or finger
- absence of distal pulses
- positive Allen test
- joint arthritis
- duration of joint symptoms up to 2 weeks
危险因素
- smoking
- age <40 years
- region of origin: southeast Mediterranean, Middle East, and Far East
- male sex
- periodontal infection
- human leukocyte antigen (HLA) haplotypes
诊断性检查
首要检查
- blood glucose
- BUN
- serum creatinine
- complete blood count (CBC) with differential
- coagulation screen
- thrombophilia screen
- C-reactive protein (CRP)
- erythrocyte sedimentation rate (ESR)
- arterial Doppler
需考虑的检查
- antinuclear antibody
- rheumatoid factor
- antineutrophilic cytoplasmic antibody (ANCA)
- complement levels
- anticentromere antibody
- topoisomerase I antibodies (Scl-70)
- echocardiogram
- arterial duplex
- digital subtraction angiography
- CT angiography
- magnetic resonance angiography
- tissue biopsy
- anticardiolipin antibodies
新兴检查
- genetic testing
治疗流程
critical ischemia
noncritical ischemia
撰稿人
作者
Matthew J. Metcalfe, MD, FRCS, FEBVS, FHEA

Consultant Vascular Surgeon
Lister Hospital
East and North Hertfordshire NHS Trust
Hertfordshire and West Essex Vascular Network
Hertfordshire
UK
利益声明
MJM declares that he has no competing interests.
Alun H. Davies, MA, DM, FRCS, FHEA

Professor of Vascular Surgery and Honorary Consultant Surgeon
Department of Vascular Surgery
Faculty of Medicine
Imperial College of Medicine
Charing Cross Hospital
London
UK
利益声明
AHD declares that he has no competing interests.
同行评议者
Kosmas I. Paraskevas, MD, FASA
Department of Vascular Surgery
Red Cross Hospital
Athens
Greece
利益声明
KIP declares that he has no competing interests.
Maureen K. Sheehan, MD
Assistant Professor of Surgery
Division of Vascular Surgery
University of Texas Health Science Center at San Antonio
San Antonio
TX
利益声明
MKS declares that she has no competing interests.
Peter F. Lawrence, MD
Chief of Vascular Surgery
Director
Gonda Vascular Center
David Geffen School of Medicine at UCLA
Los Angeles
CA
利益声明
PFL declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
参考文献
关键文献
Le Joncour A, Soudet S, Dupont A, et al. Long-term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger's disease): a multicenter study of 224 patients. J Am Heart Assoc. 2018 Dec 4;7(23):e010677.全文 摘要
Olin JW, Young JR, Graor RA, et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation. 1990 Nov;82(5 suppl):IV3-8. 摘要
Ohta T, Ishioashi H, Hosaka M, et al. Clinical and social consequences of Buerger disease. J Vasc Surg. 2004 Jan;39(1):176-80. 摘要
Cacione DG, Macedo CR, do Carmo Novaes F, et al. Pharmacological treatment for Buerger's disease. Cochrane Database Syst Rev. 2020 May 4;5:CD011033.全文 摘要
参考文献
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

鉴别诊断
- Embolic disease
- Hypercoagulable state
- Raynaud phenomenon (RP)
更多 鉴别诊断患者教育信息
Quitting smoking
更多 患者教育信息登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容
内容使用需遵循免责声明